Adenosine receptors: novel targets for drug development in allergic rhinitis.
Matera
M G
MG
Polosa
R
R
D000241:Adenosine / Q000378:metabolism*; D058918:Adenosine A3 Receptor Antagonists; D001249:Asthma / Q000188:drug therapy / Q000378:metabolism; D002908:Chronic Disease; D006801:Humans; D058915:Purinergic P1 Receptor Antagonists; D043684:Receptor, Adenosine A3 / Q000378:metabolism; D018047:Receptors, Purinergic P1 / Q000378:metabolism; D012220:Rhinitis / Q000188:drug therapy* / Q000378:metabolism*; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy / Q000378:metabolism; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*
D058918:Adenosine A3 Receptor Antagonists; D058915:Purinergic P1 Receptor Antagonists; D043684:Receptor, Adenosine A3; D018047:Receptors, Purinergic P1; D000241:Adenosine